Arcus Biosciences, Inc. (RCUS) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Arcus Biosciences, Inc. · Health Care · ref. ETF XLV · 64 calls · price $30.59
What the company does: Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
📈 Arcus Biosciences, Inc. (RCUS) stock price
$30.59+188.3% over range
Aug 28, 25low $10.59 · high $31.57Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 8 analysts
📊 JPI status : Arcus Biosciences, Inc. is no longer in our current JPI rankings, but appeared in the past (2025, 2024, 2023) — its upside may be behind it. See the stocks picked in 2025 →
🎯 RCUS price target & analyst consensus — price $30.59
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$49+60.2%
Median target · of 8 targets$44+43.8%
Lowest target · 1 firm of 8$22-28.1%
Current price$30.59
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
675%
$34 ↔ $49
Below
225%
$22 ↔ $26
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: HC Wainwright & Co. — 61% of its targets hit on this sector (321 calls tested). It aims for $45 (+47 %), call made on July 21, 2026, maturing on July 21, 2027 (38 d ago).
The 1 reliable analyst
$45+47 %
The 7 other firms
$43+41 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $45 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy675%
Hold225%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 RCUS price target all
All 64 calls, one by one, with our verdict on each firm.
→ See all 64 targets, analyst by analyst💡 The best analysts on RCUS most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in RCUS? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Arcus Biosciences, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on RCUS
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| SunTrust Robinson Humphrey | 100% | +145.5% | 2 |
| Wells Fargo ↗ | 67% | +133.5% | 3 |
| Morgan Stanley ↗ | 57% | +55.2% | 7 |
| BTIG ↗ | 50% | -9.7% | 2 |
| Barclays ↗ | 43% | +24.3% | 7 |
| SVB Leerink | 40% | -4.2% | 10 |
| Mizuho ↗ | 33% | +5.1% | 6 |
| Cantor Fitzgerald ↗ | 25% | +0.7% | 8 |
| Citigroup ↗ | 11% | -24.8% | 9 |
| Wedbush ↗ | 0% | -27.5% | 8 |
See the other 1 firms
| Truist Securities ↗ | 0% | -36.5% | 4 |
📊 What $1,000 invested in Arcus Biosciences, Inc. would be worth › open the full page
In short — $1,000 invested in Arcus Biosciences, Inc. 10 years ago would be worth $1,610 today, i.e. +6%/yr on average. Best year: 2020 (+168%), worst: 2022 (-49%). Price performance, excluding dividends.
If I'd invested $1,000 in Arcus Biosciences, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,881 | +88% |
| 3 years ago | $1,370 | +37% |
| 5 years ago | $1,091 | +9% |
Return by year (Arcus Biosciences, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +22% | $1,216 (+22%) |
| 2025 | +55% | $1,881 (+88%) |
| 2024 | -21% | $1,483 (+48%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Arcus Biosciences, Inc.
Loading news…
📋 All analyst calls on RCUS
Filtered on — · ✕ show all
Wells Fargo ↗
Aug 6, 26
■ Equal-Weight neutral · not a buy · 🎯$26
Price at call : $28.62 — gap to target -9%
Today : $30.59 — gap to target -15%
🎯 on RCUS : 67% (3 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Outperform · 🎯$43
Price at call : $28.62 — upside +50%
Today : $30.59 — upside +41%
🎯 on RCUS : 0% (8 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
HC Wainwright & Co. ↗
Jul 20, 26
▲ Buy · 🎯$45
Price at call : $28.17 — upside +60%
Today : $30.59 — upside +47%
🎯 on RCUS : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Jul 20, 27
matures : Jul 20, 27
LifeSci Capital
Jun 4, 26
▲ Outperform · 🎯$46
Price at call : $23.19 — upside +98%
Today : $30.59 — upside +50%
🎯 on RCUS : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Morgan Stanley ↗
May 11, 26
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $24.9 — gap to target -12%
Today : $30.59 — gap to target -28%
🎯 on RCUS : 75% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
Goldman Sachs ↗
May 7, 26
▲ Buy · 🎯$34
Price at call : $25.36 — upside +34%
Today : $30.59 — upside +11%
🎯 on RCUS : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Outperform · 🎯$41
Price at call : $22.96 — upside +79%
Today : $30.59 — upside +34%
🎯 on RCUS : 0% (8 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
in progress (365j)
matures : Apr 2, 27
matures : Apr 2, 27
▲ Buy · 🎯$45
Price at call : $22.11 — upside +104%
Today : $30.59 — upside +47%
🎯 on RCUS : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
See the other 56 calls, newest to oldest
Leerink Partners ↗
Mar 2, 26
▲ Outperform · 🎯$49
Price at call : $22.43 — upside +118%
Today : $30.59 — upside +60%
🎯 on RCUS : no call matured yet · 📊 on Health : 50% · -5.3% (10 calls)
in progress (365j)
matures : Mar 2, 27
matures : Mar 2, 27
HC Wainwright & Co. ↗
Mar 2, 26
▲ Buy · 🎯$32
Price at call : $23.94 — upside +34%
Today : $30.59 — upside +5%
🎯 on RCUS : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Mar 2, 27
matures : Mar 2, 27
Wells Fargo ↗
Feb 12, 26
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $19.96 — gap to target +15%
Today : $30.59 — gap to target -25%
🎯 on RCUS : 67% (3 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
Goldman Sachs ↗
Jan 13, 26
▲ Buy · 🎯$28
Price at call : $24.56 — upside +14%
Today : $30.59 — upside -8%
🎯 on RCUS : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Jan 13, 27
matures : Jan 13, 27
Morgan Stanley ↗
Jan 8, 26
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $21.35 — gap to target -6%
Today : $30.59 — gap to target -35%
🎯 on RCUS : 75% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
HC Wainwright & Co. ↗
Dec 12, 25
▲ Buy · 🎯$32
Price at call : $21.91 — upside +46%
Today : $30.59 — upside +5%
🎯 on RCUS : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Dec 12, 26
matures : Dec 12, 26
B of A Securities ↗
Nov 28, 25
■ Neutral neutral · not a buy · 🎯$26
Price at call : $26.1 — gap to target -0%
Today : $30.59 — gap to target -15%
🎯 on RCUS : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Nov 28, 26
matures : Nov 28, 26
Goldman Sachs ↗
Oct 30, 25
■ Neutral neutral · not a buy · 🎯$16
Price at call : $19.72 — gap to target -19%
Today : $30.59 — gap to target -48%
🎯 on RCUS : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
▲ Buy · 🎯$56
Price at call : $20.19 — upside +177%
Today : $30.59 — upside +83%
🎯 on RCUS : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
HC Wainwright & Co. ↗
Oct 29, 25
▲ Buy · 🎯$28
Price at call : $20.29 — upside +38%
Today : $30.59 — upside -8%
🎯 on RCUS : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
Wells Fargo ↗
Oct 20, 25
▲ Overweight · 🎯$29
Price at call : $18.05 — upside +61%
Today : $30.59 — upside -5%
🎯 on RCUS : 67% (3 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Oct 20, 26
matures : Oct 20, 26
▲ Buy · 🎯$54
Price at call : $15.62 — upside +246%
Today : $30.59 — upside +77%
🎯 on RCUS : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Oct 13, 26
matures : Oct 13, 26
Truist Securities ↗
Oct 7, 25
▲ Buy · 🎯$39
Price at call : $15.05 — upside +159%
Today : $30.59 — upside +27%
🎯 on RCUS : 0% (2 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
Morgan Stanley ↗
Aug 7, 25
▲ Overweight · 🎯$23
Price at call : $9.06 — upside +154%
Today : $30.59 — upside -25%
Expected +154% · Actual +217% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 75% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+217.0%
stock +217% · XLV +29%
matured Aug 7, 26
Wells Fargo ↗
Aug 7, 25
▲ Overweight · 🎯$25
Price at call : $9.06 — upside +176%
Today : $30.59 — upside -18%
Expected +176% · Actual +217% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 67% (3 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+217.0%
stock +217% · XLV +29%
matured Aug 7, 26
Morgan Stanley ↗
May 9, 25
▲ Overweight · 🎯$22
Price at call : $8.8 — upside +150%
Today : $30.59 — upside -28%
Expected +150% · Actual +183% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 75% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+182.5%
stock +183% · XLV +5%
matured May 9, 26
Goldman Sachs ↗
May 8, 25
■ Neutral neutral · not a buy · 🎯$13
Price at call : $8.28 — gap to target +57%
Today : $30.59 — gap to target -58%
🎯 on RCUS : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : May 8, 26
matures : May 8, 26
Wells Fargo ↗
May 7, 25
▲ Overweight · 🎯$26
Price at call : $8.53 — upside +205%
Today : $30.59 — upside -15%
Expected +205% · Actual +197% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 67% (3 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+197.3%
stock +197% · XLV +7%
matured May 7, 26
▲ Overweight · 🎯$14
Price at call : $8.11 — upside +73%
Today : $30.59 — upside -54%
Expected +73% · Actual +210% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 67% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
+209.9%
stock +210% · XLV +8%
matured Apr 23, 26
HC Wainwright & Co. ↗
Feb 26, 25
▲ Buy · 🎯$24
Price at call : $10.14 — upside +137%
Today : $30.59 — upside -22%
Expected +137% · Actual +93% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)
+92.7%
stock +93% · XLV +6%
matured Feb 26, 26
B of A Securities ↗
Feb 19, 25
■ Neutral neutral · not a buy · 🎯$17
Price at call : $11.1 — gap to target +53%
Today : $30.59 — gap to target -44%
🎯 on RCUS : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Feb 19, 26
matures : Feb 19, 26
HC Wainwright & Co. ↗
Feb 18, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $11.1 — gap to target +62%
Today : $30.59 — gap to target -41%
🎯 on RCUS : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Feb 18, 26
matures : Feb 18, 26
Morgan Stanley ↗
Feb 18, 25
▲ Overweight · 🎯$25
Price at call : $11.1 — upside +125%
Today : $30.59 — upside -18%
Expected +125% · Actual +76% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 75% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+75.5%
stock +76% · XLV +7%
matured Feb 18, 26
HC Wainwright & Co. ↗
Nov 6, 24
■ Neutral neutral · not a buy · 🎯$20
Price at call : $15.73 — gap to target +27%
Today : $30.59 — gap to target -35%
🎯 on RCUS : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Nov 6, 25
matures : Nov 6, 25
▲ Overweight · 🎯$29
Price at call : $16.66 — upside +74%
Today : $30.59 — upside -5%
Expected +74% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 67% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
+11.6%
stock +12% · XLV -2%
matured Oct 25, 25
HC Wainwright & Co. ↗
Oct 24, 24
■ Neutral neutral · not a buy · 🎯$20
Price at call : $16.32 — gap to target +23%
Today : $30.59 — gap to target -35%
🎯 on RCUS : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Oct 24, 25
matures : Oct 24, 25
HC Wainwright & Co. ↗
Oct 21, 24
■ Neutral neutral · not a buy · 🎯$20
Price at call : $16.97 — gap to target +18%
Today : $30.59 — gap to target -35%
🎯 on RCUS : 100% (1 call matured) · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Oct 21, 25
matures : Oct 21, 25
Wells Fargo ↗
Oct 8, 24
▲ Overweight · 🎯$29
Price at call : $17.47 — upside +66%
Today : $30.59 — upside -5%
Expected +66% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 67% (3 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
-13.9%
stock -14% · XLV -5%
matured Oct 8, 25
Cantor Fitzgerald ↗
Oct 7, 24
▲ Overweight
Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 25% (8 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-13.9%
stock -14% · XLV -5%
matured Oct 7, 25
Cantor Fitzgerald ↗
Oct 3, 24
▲ Overweight
Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 25% (8 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-13.0%
stock -13% · XLV -5%
matured Oct 3, 25
▲ Outperform · 🎯$30
Price at call : $16.65 — upside +80%
Today : $30.59 — upside -2%
Expected +80% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (8 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-13.0%
stock -13% · XLV -5%
matured Oct 3, 25
Cantor Fitzgerald ↗
Aug 9, 24
▲ Overweight
Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 25% (8 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-38.7%
stock -39% · XLV -13%
matured Aug 9, 25
▲ Outperform · 🎯$30
Price at call : $14.95 — upside +101%
Today : $30.59 — upside -2%
Expected +101% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (8 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-38.7%
stock -39% · XLV -13%
matured Aug 9, 25
B of A Securities ↗
Aug 9, 24
■ Neutral neutral · not a buy · 🎯$23
Price at call : $15.61 — gap to target +47%
Today : $30.59 — gap to target -25%
🎯 on RCUS : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Aug 9, 25
matures : Aug 9, 25
▲ Overweight · 🎯$25
Price at call : $14.08 — upside +78%
Today : $30.59 — upside -18%
Expected +78% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 67% (3 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
-33.7%
stock -34% · XLV -7%
matured Jul 8, 25
Cantor Fitzgerald ↗
Jul 5, 24
▲ Overweight
Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 25% (8 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-40.6%
stock -41% · XLV -7%
matured Jul 5, 25
Truist Securities ↗
Jun 24, 24
▲ Buy · 🎯$44
Price at call : $15.83 — upside +178%
Today : $30.59 — upside +44%
Expected +178% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (2 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-45.6%
stock -46% · XLV -9%
matured Jun 24, 25
▲ Buy · 🎯$38
Price at call : $16 — upside +138%
Today : $30.59 — upside +24%
Expected +138% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (1 call matured) · 📊 on Health : 43.8% · -5.4% (105 calls)
-40.0%
stock -40% · XLV -8%
matured Jun 3, 25
Morgan Stanley ↗
May 13, 24
▲ Overweight · 🎯$40
Price at call : $17.21 — upside +132%
Today : $30.59 — upside +31%
Expected +132% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 75% (4 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-49.6%
stock -50% · XLV -8%
matured May 13, 25
▲ Outperform · 🎯$30
Price at call : $16.15 — upside +86%
Today : $30.59 — upside -2%
Expected +86% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (8 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-48.7%
stock -49% · XLV -7%
matured May 9, 25
Truist Securities ↗
Mar 25, 24
▲ Buy · 🎯$50
Price at call : $16.65 — upside +200%
Today : $30.59 — upside +63%
Expected +200% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (2 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-50.4%
stock -50% · XLV -1%
matured Mar 25, 25
▲ Outperform · 🎯$30
Price at call : $19.67 — upside +53%
Today : $30.59 — upside -2%
Expected +53% · Actual -44% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (8 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-43.7%
stock -44% · XLV -1%
matured Feb 21, 25
▲ Outperform · 🎯$30
Price at call : $15.14 — upside +98%
Today : $30.59 — upside -2%
Expected +98% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (8 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-11.6%
stock -12% · XLV +5%
matured Jan 29, 25
▲ Buy · 🎯$42
Price at call : $15.14 — upside +177%
Today : $30.59 — upside +37%
Expected +177% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 33% (6 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-11.6%
stock -12% · XLV +5%
matured Jan 29, 25
▲ Outperform · 🎯$36
Price at call : $17 — upside +112%
Today : $30.59 — upside +18%
Expected +112% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (8 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-16.9%
stock -17% · XLV +1%
matured Jan 16, 25
Cantor Fitzgerald ↗
Nov 8, 23
▲ Overweight · 🎯$36
Price at call : $13.74 — upside +162%
Today : $30.59 — upside +18%
Expected +162% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 25% (8 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+29.9%
stock +30% · XLV +20%
matured Nov 7, 24
▲ Buy · 🎯$51
Price at call : $15.82 — upside +222%
Today : $30.59 — upside +67%
Expected +222% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 33% (6 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-3.2%
stock -3% · XLV +18%
matured Oct 2, 24
Cantor Fitzgerald ↗
Sep 12, 23
▲ Overweight · 🎯$46
Price at call : $21.25 — upside +116%
Today : $30.59 — upside +50%
Expected +116% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 25% (8 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-20.1%
stock -20% · XLV +17%
matured Sep 11, 24
Cantor Fitzgerald ↗
Sep 7, 23
▲ Overweight · 🎯$46
Price at call : $21.38 — upside +115%
Today : $30.59 — upside +50%
Expected +115% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 25% (8 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-23.7%
stock -24% · XLV +17%
matured Sep 6, 24
▲ Buy · 🎯$51
Price at call : $22.92 — upside +123%
Today : $30.59 — upside +67%
Expected +123% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 33% (6 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-21.4%
stock -21% · XLV +17%
matured Aug 22, 24
▲ Outperform · 🎯$36
Price at call : $18.02 — upside +100%
Today : $30.59 — upside +18%
Expected +100% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 0% (8 calls matureds) · 📊 on Health : 35.8% · +3.2% (53 calls)
-7.3%
stock -7% · XLV +8%
matured May 9, 24
▲ Buy · 🎯$51
Price at call : $16.45 — upside +210%
Today : $30.59 — upside +67%
Expected +210% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 33% (6 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
+4.7%
stock +5% · XLV +15%
matured Mar 16, 24
▲ Buy · 🎯$40
Price at call : $31.79 — upside +26%
Today : $30.59 — upside +31%
Expected +26% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on RCUS : 33% (6 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-10.3%
stock -10% · XLV +24%
matured May 14, 21
Cantor Fitzgerald ↗
Apr 3, 20
▲ Overweight · 🎯$21
Price at call : $14.44 — upside +45%
Today : $30.59 — upside -31%
Expected +45% · Actual +126% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 25% (8 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+125.6%
stock +126% · XLV +35%
matured Apr 3, 21
▲ Buy · 🎯$22
Price at call : $10.18 — upside +116%
Today : $30.59 — upside -28%
Expected +116% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on RCUS : 33% (6 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
+72.3%
stock +72% · XLV +16%
matured Sep 26, 20
Frequently asked questions
Should I buy Arcus Biosciences, Inc. stock?
This isn't buy advice. For Arcus Biosciences, Inc., the analyst consensus is "Buy", with an average price target of $44.00 (+44% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Arcus Biosciences, Inc.). We show the numbers — you decide.
Is it too late to buy Arcus Biosciences, Inc.? How high can it go?
The most bullish analyst target on Arcus Biosciences, Inc. is $49.00 (+60% above today's price); the average is $44.00. That's the upside they see. Check how reliable those analysts have actually been on Arcus Biosciences, Inc. on our site before trusting it.
Is Arcus Biosciences, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Arcus Biosciences, Inc., the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Arcus Biosciences, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in RCUS (and why hesitate).
What has Arcus Biosciences, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: RCUS performance & returns.
What is the best month to buy RCUS?
The 12 months ranked by the stock's past returns: best & worst month to buy RCUS.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX